Highlights Divi's Laboratories Limited

Stocks

DIVISLAB

INE361B01024

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:07 08/06/2026 pm IST			5-day change	1st Jan Change
6,521.00 ^INR	-1.54%		-0.50%	+2.01%

26/05	Divi's Laboratories Limited announces Annual dividend, payable on September 09, 2026	CI
25/05	Choice Equity Upgrades Divi's Laboratories to Add from Reduce; Price Target is INR7,375	MT

Highlights

26/05	Divi's Laboratories Limited announces Annual dividend, payable on September 09, 2026	CI
25/05	Divi's Laboratories Clocks Gains in Fiscal Q4 Consolidated Profit	MT
23/05	Divi's Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
11/02	Divi's Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11/02	Indian contract drug maker Divi's misses profit view on high material costs, one-off labour charge	RE
11/02	Divi's Laboratories Q3 consol net profit 5.83 billion rupees	RE
07/11	Divi's Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
07/11	Divi's Laboratories' Consolidated Profit Grows in Fiscal Q2	MT
07/11	Indian drugmaker Divi's beats profit view for second quarter on API boost	RE
07/11	Divi's Labs Sept-quarter consol net profit 6.89 billion rupees	RE
06/25/06	Divi's Laboratories' Consolidated Profit Grows in Fiscal Q1; Shares Down Over 3%	MT
06/25/06	Divi's Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
06/25/06	Indian drugmaker Divi's misses June-quarter profit view on weak US pricing	RE
25/25/25	For final dividend	FA
20/25/20	Divi's Laboratories Limited announces Annual dividend, payable on September 10, 2025	CI
19/25/19	Divi's Laboratories Posts Gains in Fiscal Q4 Consolidated Profit; Shares up 5%	MT
17/25/17	Divi's Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
04/25/04	Divi's Laboratories Posts Gains in Fiscal Q3 Consolidated Profit	MT
03/25/03	India's Divi's Labs beats Q3 profit estimates on strong API demand; shares rise	RE
03/25/03	Divi's Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
02/25/02	Divi's Laboratories Limited Announces Commencement of Commercial Operations at Unit III Greenfield Project at Kakinada, Andhra Pradesh in Phased Managed	CI
11/24/11	Jefferies Adjusts Divi's Laboratories' Price Target to INR5,790 From INR4,830, Keeps at Hold	MT
11/24/11	Divi's Laboratories Posts Gains in Fiscal Q2 Consolidated Profit	MT
09/24/09	Divi's Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
12/24/12	Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2024	CI